These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 14534540)
1. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells. Starczynowski DT; Reynolds JG; Gilmore TD Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540 [TBL] [Abstract][Full Text] [Related]
2. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability. Starczynowski DT; Reynolds JG; Gilmore TD Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730 [TBL] [Abstract][Full Text] [Related]
3. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity. Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339 [TBL] [Abstract][Full Text] [Related]
4. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells. Epinat JC; Dvorin EL; Gilmore TD Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567 [TBL] [Abstract][Full Text] [Related]
5. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes. Fan Y; Rayet B; Gélinas C Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412 [TBL] [Abstract][Full Text] [Related]
6. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation. Fan Y; Gélinas C Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064 [TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834 [TBL] [Abstract][Full Text] [Related]
8. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation. Zurovec M; Petrenko O; Roll R; Enrietto PJ Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392 [TBL] [Abstract][Full Text] [Related]
9. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein. Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504 [TBL] [Abstract][Full Text] [Related]
10. Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Hannink M; Temin HM Mol Cell Biol; 1989 Oct; 9(10):4323-36. PubMed ID: 2555689 [TBL] [Abstract][Full Text] [Related]
11. Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3. Barkett M; Dooher JE; Lemonnier L; Simmons L; Scarpati JN; Wang Y; Gilmore TD Biochim Biophys Acta; 2001 Apr; 1526(1):25-36. PubMed ID: 11287119 [TBL] [Abstract][Full Text] [Related]
12. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins. Gilmore TD; Gélinas C Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells. Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488 [TBL] [Abstract][Full Text] [Related]
14. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site. Capobianco AJ; Gilmore TD Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669 [TBL] [Abstract][Full Text] [Related]
15. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain. Sarkar S; Gilmore TD Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947 [TBL] [Abstract][Full Text] [Related]
16. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. Gilmore TD; Temin HM J Virol; 1988 Mar; 62(3):703-14. PubMed ID: 2828665 [TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Capobianco AJ; Simmons DL; Gilmore TD Oncogene; 1990 Mar; 5(3):257-65. PubMed ID: 2179815 [TBL] [Abstract][Full Text] [Related]
18. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids. Kralova J; Schatzle JD; Bargmann W; Bose HR J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992 [TBL] [Abstract][Full Text] [Related]
19. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts. Morrison LE; Boehmelt G; Enrietto PJ Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245 [TBL] [Abstract][Full Text] [Related]
20. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]